FINANCE
Injective Gains Over 10% as Nasdaq Approves Canary's Staked INJ ETF
Injective gains more than 10% after Nasdaq approves the listing of Canary Capital's Staked INJ ETF. The fund plans to stake at least 90% of its INJ holdings.
READ MORE AT SOURCE »
Originally reported by Altcoin Buzz
HOW DO YOU SEE THIS STORY?
Choose your pill. Your vote is anonymous.
0 TOTAL VOTES
SCAN TO SHARE
« Back to The Culture War
